Literature DB >> 17405187

Hepatocyte growth factor and c-Met expression in pericytes: implications for atherosclerotic plaque development.

Y Liu1, F L Wilkinson, J P Kirton, M Jeziorska, H Iizasa, Y Sai, E Nakashima, A M Heagerty, A E Canfield, M Y Alexander.   

Abstract

Intraplaque neovascularization contributes to the progression of atherosclerosis. Our aim is to understand the mobilization of cells and factors involved in this process. We investigated the localization of hepatocyte growth factor (HGF) and its receptor, c-Met, in human atherosclerotic plaques, together with the effects of HGF on pericyte migration in vitro. Atherosclerotic femoral arterial segments were collected and analysed from 13 subjects who were undergoing lower limb amputation. Pericytes were identified in human lesions using a 3G5 antibody. Immunohistochemical analysis localized HGF mainly around microvessels, in association with some, but not all, CD31-positive endothelial cells. c-Met expression was mainly associated with smooth muscle cells and pericytes, around some, but not all, microvessels within the atherosclerotic lesions; no detection was apparent in normal internal mammary arteries. Using RT-PCR, we demonstrated expression of HGF and c-Met in a rat pericyte cell-line, TR-PCT1, and in primary pericytes. HGF treatment of TR-PCT1 cells induced their migration, but not their proliferation, in a dose-dependent manner (10-100 ng/ml, p<0.01), an effect mediated by activation of the serine/threonine kinase Akt, shown by western blot analysis. Treating the cells with the PI3K inhibitors Wortmannin (0.1 microM) or LY294002 (10 microM) abolished these effects. This work demonstrates the expression of c-Met and HGF in human atherosclerotic arteries, in association with SM-actin-positive cells and CD-31-positive cells, respectively. HGF induces pericyte migration via PI3-kinase and Akt activation in vitro. HGF and c-Met may be involved in neovascularization during plaque development, and may recruit pericytes to neovessels. Since pericytes are thought to mechanically stabilize new blood vessels, these factors may function to protect against haemorrhage. Copyright (c) 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17405187     DOI: 10.1002/path.2155

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  25 in total

1.  Intimal pericytes as the second line of immune defence in atherosclerosis.

Authors:  Ekaterina A Ivanova; Yuri V Bobryshev; Alexander N Orekhov
Journal:  World J Cardiol       Date:  2015-10-26

2.  Dissecting the role of human embryonic stem cell-derived mesenchymal cells in human umbilical vein endothelial cell network stabilization in three-dimensional environments.

Authors:  Nolan L Boyd; Sara S Nunes; Laxminarayanan Krishnan; Jenny D Jokinen; Venkat M Ramakrishnan; Amy R Bugg; James B Hoying
Journal:  Tissue Eng Part A       Date:  2012-09-12       Impact factor: 3.845

3.  Serum Hepatocyte Growth Factor Is Probably Associated With 3-Month Prognosis of Acute Ischemic Stroke.

Authors:  Zhengbao Zhu; Tan Xu; Daoxia Guo; Xinfeng Huangfu; Chongke Zhong; Jingyuan Yang; Aili Wang; Chung-Shiuan Chen; Yanbo Peng; Tian Xu; Jinchao Wang; Yingxian Sun; Hao Peng; Qunwei Li; Zhong Ju; Deqin Geng; Jing Chen; Yonghong Zhang; Jiang He
Journal:  Stroke       Date:  2018-01-10       Impact factor: 7.914

4.  Hepatocyte growth factor and the risk of ischemic stroke developing among postmenopausal women: results from the Women's Health Initiative.

Authors:  Swapnil N Rajpathak; Tao Wang; Sylvia Wassertheil-Smoller; Howard D Strickler; Robert C Kaplan; Aileen P McGinn; Rachel P Wildman; Daniel Rosenbaum; Thomas E Rohan; Philipp E Scherer; Mary Cushman; Gloria Y F Ho
Journal:  Stroke       Date:  2010-03-04       Impact factor: 7.914

Review 5.  The role of cell plasticity in progression and reversal of renal fibrosis.

Authors:  Jean-Claude Dussaule; Dominique Guerrot; Anne-Cécile Huby; Christos Chadjichristos; Nasim Shweke; Jean-Jacques Boffa; Christos Chatziantoniou
Journal:  Int J Exp Pathol       Date:  2011-02-12       Impact factor: 1.925

6.  Renal expression of alpha-smooth muscle actin and c-Met in children with Henoch-Schönlein purpura nephritis.

Authors:  Yukihiko Kawasaki; Tomoko Imaizumi; Hiromi Matsuura; Shinichirou Ohara; Kei Takano; Kazuhide Suyama; Koichi Hashimoto; Ruriko Nozawa; Hitoshi Suzuki; Mitsuaki Hosoya
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

7.  Thin-walled microvessels in human coronary atherosclerotic plaques show incomplete endothelial junctions relevance of compromised structural integrity for intraplaque microvascular leakage.

Authors:  Judith C Sluimer; Frank D Kolodgie; Ann P J J Bijnens; Kimberly Maxfield; Erica Pacheco; Bob Kutys; Hans Duimel; Peter M Frederik; Victor W M van Hinsbergh; Renu Virmani; Mat J A P Daemen
Journal:  J Am Coll Cardiol       Date:  2009-04-28       Impact factor: 24.094

Review 8.  Preclinical and clinical evaluation of MET functions in cancer cells and in the tumor stroma.

Authors:  V Finisguerra; H Prenen; M Mazzone
Journal:  Oncogene       Date:  2016-03-21       Impact factor: 9.867

9.  Vascular endothelial growth factor, its soluble receptor, and hepatocyte growth factor: clinical and genetic correlates and association with vascular function.

Authors:  Wolfgang Lieb; Radwan Safa; Emelia J Benjamin; Vanessa Xanthakis; Xiaoyan Yin; Lisa M Sullivan; Martin G Larson; Holly M Smith; Joseph A Vita; Gary F Mitchell; Douglas B Sawyer; Ramachandran S Vasan
Journal:  Eur Heart J       Date:  2009-02-17       Impact factor: 29.983

10.  Fetuin-A influences vascular cell growth and production of proinflammatory and angiogenic proteins by human perivascular fat cells.

Authors:  Dorothea I Siegel-Axel; Susanne Ullrich; Norbert Stefan; Kilian Rittig; Felicia Gerst; Christian Klingler; Ulrike Schmidt; Birgit Schreiner; Elko Randrianarisoa; Hans-Eberhard Schaller; Ulrich A Stock; Cora Weigert; Alfred Königsrainer; Hans-Ulrich Häring
Journal:  Diabetologia       Date:  2014-02-04       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.